DRIVE-AB: Driving re-investment in R&D and responsible antibiotic use

Beskrivning

DRIVE-AB (www.drive-ab.eu), financed by IMI (Innovative Medicines Initiative), is a joint undertaking between the EU and the European Pharmaceutical Industry Association that is tasked with developing new economic models to incentivize R&D in antibiotics. In this project, the Department of Business Studies has leading roles in both research and project management and works with pharmaceutical firms and policy-makers to identify challenges to antibiotic R&D and suggest how these challenges may be overcome using incentives and policy changes that target companies’ business models and the existing business cases that guide antibiotic R&D. With the confines of the DRIVE-AB project, the Department is partnered with 15 universities (e.g. Princeton, LSE, Boston, Geneva) and 7 pharmaceutical companies (e.g. AstraZeneca, GSK, Roche, Pfizer) from 12 countries. Moreover, in this project our Department also collaborates with external stakeholders such as WHO, UN, World Bank, and about 60 European SMEs. Within Uppsala University, the DRIVE-AB project entails also collaboration between the Department of Business Studies and the ReAct center, the Uppsala Antibiotic Center, as well as with several departments, faculties, and research groups from Information Systems, Law, Medicine and Pharmaceutics, Global Health, Economic history, and Engineering.